Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Oscar Lambret
With
CTD-CNO
Laboratoire PRISM
Most of ovarian carcinomas related to BRCA 1 or 2 mutations are of fallopian tube origin and especially from its distant part called the fimbria. These tubal, ovarian or primary peritoneal carcinomas are quite always of high grade serous type. They cannot be effectively screened due to the quickness of their evolution. In this context, a laparoscopic bilateral salpingo-oophorectomy (BSO) is the recommended prophylactic procedure.
Some BRCA-mutated women are reluctant to undergo this procedure considering the numerous adverse effects on body and quality of life, especially when hormonal replacement is forbidden. This refusal makes them at risk of developing a serous pelvic carcinoma.
The goal of the bilateral laparoscopic radical fimbriectomy the investigators suggest, is to suppress the tubal source of possible dysplastic cells from which can stem this high grade tumor, while preserving a natural ovarian hormonal secretion
Age
35–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Woman aged over 35 years
When project of childbearing is fulfilled
With a BRCA 1 or 2 mutation, or a family history of breast/ovarian cancer
Unprepared to undergo bilateral annexectomy
With or without breast cancer
Patient affiliated to health insurance
Dated and signed informed consent
You may not be if
Menopausal woman defined as :
Bilateral oophorectomy without hysterectomy and amenorrhea more than 12 months and/or FSH\> 20 UI/l History of hysterectomy and FSH\> 20 UI/l